Igm Biosciences share price today

(IGMS)

Igm Biosciences share price is $9.25 & -₹9.25 as on 12 Dec 2024, 2.30 'hrs' IST

$9.25

▲

-0.24

(-2.53%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Igm Biosciences share price in Dollar and Rupees. Guide to invest in Igm Biosciences from India. Also see the sentimental analysis on Indian investors investing in Igm Biosciences. Get details on the Indian mutual funds that are investing in Igm Biosciences. Get Analyst recommendations and forecasts along with all the Igm Biosciences's financials.

Igm Biosciences share price movements

$9.24
$9.77
$9.25
0.12%
Downside
Day's Volatility :5.44%
Upside
5.32%
$5.58
$22.50
$9.25
39.68%
Downside
52 Weeks Volatility :75.2%
Upside
58.89%

Igm Biosciences Returns

Period	Igm Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.79%	-8.8%	0.0%
6 Months	16.5%	-2.7%	0.0%
1 Year	47.06%	6.5%	0.0%
3 Years	-68.38%	5.6%	-20.0%

Igm Biosciences Key Statistics

in dollars & INR

Previous Close	$9.49
Open	$9.54
Today's High	$9.77
Today's Low	$9.2388
Market Capitalization	$564.3M
Today's Volume	$130.7K
52 Week High	$22.5
52 Week Low	$5.58
Revenue TTM	$2.9M
EBITDA	$-224.0M
Earnings Per Share (EPS)	$-3.61
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-132.11%

How to invest in Igm Biosciences from India?

It is very easy for Indian residents to invest directly in Igm Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Igm Biosciences stock in both rupees (INR) and dollars (USD). Search for Igm Biosciences or IGMS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Igm Biosciences or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Igm Biosciences shares which would translate to -0.001 fractional shares of Igm Biosciences as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Igm Biosciences

-38%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Igm Biosciences on INDmoney from India has reduced in the last 30 days as on Dec 12, 2024. -38% less investors are searching Igm Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Igm Biosciences

Baker Bros Advisors LP
6.88%
T. Rowe Price Associates, Inc.
6.75%
Redmile Group, LLC
5.17%
Goldman Sachs Group Inc
2.12%
Vanguard Group Inc
1.50%
BlackRock Inc
1.49%

Analyst Recommendation on Igm Biosciences

Buy

66%Buy

33%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Igm Biosciences(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Igm Biosciences

What analysts predicted

Upside of 113.27%

Current:

$9.25

Target:

$19.73

Insights on Igm Biosciences

Price Movement
In the last 1 month, IGMS stock has moved down by -18.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 1.25M → 516.0K (in $), with an average decrease of 58.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -47.90M → -61.43M (in $), with an average decrease of 28.2% per quarter
IGMS vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.4% return, outperforming this stock by 127.8%

Igm Biosciences Technicals Summary

Sell

Neutral

Buy

Igm Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Igm Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Igm Biosciences Inc	-18.5%	16.5%	47.06%	-68.38%	-69.31%
Regeneron Pharmaceuticals, Inc.	-5.85%	-24.7%	-11.77%	17.09%	105.58%
Biontech Se	12.25%	24.31%	22.8%	-57.11%	240.97%
Alnylam Pharmaceuticals, Inc.	-5.5%	58.79%	40.79%	36.33%	111.58%
Vertex Pharmaceuticals Incorporated	-4.43%	-2.24%	15.61%	124.98%	113.34%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Igm Biosciences Inc	NA	NA	NA	-3.38	-1.32	-0.37	NA	1.33
Regeneron Pharmaceuticals, Inc.	19.27	19.27	1.17	45.03	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.24	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Igm Biosciences Inc	Buy	$564.3M	-69.31%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$86.6B	105.58%	19.27	33.61%
Biontech Se	Buy	$28.0B	240.97%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	111.58%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$122.1B	113.34%	32.84	-4.51%

About Igm Biosciences

igm biosciences, inc., a biotechnology company, engages in the research and development of immunoglobulin m (igm) antibodies for the treatment of cancer. the company's lead product candidate is igm-2323, a bispecific igm antibody that is in phase 1 clinical trials to treat patients with b cell nhl and other b cell malignancies. it is also developing igm-8444, an igm antibody targeting death receptor 5 proteins; and igm-7354, is a bispecific igm antibody delivering interleukin-15 cytokines to pd-l1 expressing cells for use in the treatment of patients with solid and hematologic malignancies. igm biosciences, inc. has a collaboration with atreca inc. and beigene ltd. to discover, develop, and manufacture novel igm and iga antibodies targeting sars-cov-2 for the potential treatment of covid-19; and strategic research collaboration and license agreement with abcellera to discover and develop igm antibodies. the company was formerly known as palingen, inc. and changed its name to igm biosci

Organization	Igm Biosciences
Employees	198
CEO	Ms. Mary Beth Harler M.D.
Industry	Health Technology

Management People of Igm Biosciences

Name	Title
Ms. Mary Beth Harler M.D.	CEO & Director
Mr. Misbah Tahir CPA	Chief Financial Officer
Mr. TS Harigopal	Senior Vice President of Group Operations
Mr. Steven Weber	Senior VP, Corporate Controller & Principal Accounting Officer
Mr. Paul C. Graffagnino J.D.	Senior Vice President of Legal Affairs
Ms. Suzette Tauber	Chief Human Resources Officer
Dr. Angus M. Sinclair Ph.D.	Executive Vice President of Research
Dr. Lisa L. Decker Ph.D.	Chief Business Officer
Dr. Marvin S. Peterson Ph.D.	Executive Vice President of Process Development & Manufacturing
Dr. Elizabeth Haanes J.D., Ph.D.	Senior Vice President of Intellectual Property

Important FAQs about investing in Igm Biosciences from India :

What is Igm Biosciences share price today?

Igm Biosciences (IGMS) share price today is $9.25.

Can Indians buy Igm Biosciences shares?

Yes, Indians can invest in the Igm Biosciences (IGMS) from India.

With INDmoney, you can buy Igm Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Igm Biosciences at zero transaction cost.

How can I buy Igm Biosciences shares from India?

It is very easy to buy Igm Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Igm Biosciences be purchased?

Yes, you can buy fractional shares of Igm Biosciences with INDmoney app.

What are the documents required to start investing in Igm Biosciences stocks?

To start investing in Igm Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.